Illustration: Brian Wang

Chinese biotechs, flushed with funds and armed with ideas, join the race to find a coronavirus cure as pandemic ravages the world

  • I-Mab Biopharma will soon start clinical trial on a drug that shows promise against Covid-19, while Cansino Biologics’ trial on a vaccine has been approved by Chinese authorities
  • Song Ruilin, the head of China Pharmaceutical Innovation and Research Development Association, says the policies launched in 2008 to support development of new drugs are now starting to pay off
Topic |   Pharmaceuticals
Illustration: Brian Wang